Pharmed
ActiveSummary
Pharmed has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €44,788 and a net result of €1,022. Equity remains stable across the filed financial years (±0% per year). Its solvency ranks better than 42% of 22,195 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
27-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 27 days late
2025
31-12
Financial
Weakest financial yearnet €1,022 ▼97.9%
Net result drops to €1,022, the lowest in the series.
11-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 11 days late
2024
31-12
Financial
Highest result from 2018 to 2025net €47,711 ▲71.3%
Operating result €66,352, net result €47,711, both a record.
21-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 21 days late
2023
09-08
NBB filing
Annual accounts filed
financial year 2022 · micro format · 9 days late
2022
13-07
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
31-08
NBB filing
Annual accounts filed
financial year 2020 · micro format · 31 days late
2020
01-09
NBB filing
Annual accounts filed
financial year 2019 · micro format · 32 days late
2019
02-08
NBB filing
Annual accounts filed
financial year 2018 · micro format · 2 days late
2018
31-08
NBB filing
Annual accounts filed
financial year 2017 · micro format · 31 days late
2017
29-08
NBB filing
Annual accounts filed
financial year 2016 · micro format · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 12 annual accounts filed, the latest 10 are here; all are under Financials.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.